Evidence map›Paper›PMID 39773039›Full record

ReviewCurrent medicinal chemistry2025

Advances and Challenges in Molecular Docking Applied to Neglected Tropical Diseases.

Rafaela Molina de Angelo, Lucas Alex Nascimento, Joao Pedro Portilho Encide, Henrique Barbosa, Joao Henrique Ghilardi Lago, Flavio da Silva Emery, Kathia Maria Honorio

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rafaela Molina de AngeloCenter for Natural and Human Sciences, Federal University of ABC, Santo André, SP, Brazil.
Lucas Alex NascimentoFaculty of Pharmaceutical Sciences, University of São Paulo, Ribeirão Preto, SP, Brazil.
Joao Pedro Portilho EncideCenter for Natural and Human Sciences, Federal University of ABC, Santo André, SP, Brazil.
Henrique BarbosaCenter for Natural and Human Sciences, Federal University of ABC, Santo André, SP, Brazil.
Joao Henrique Ghilardi LagoCenter for Natural and Human Sciences, Federal University of ABC, Santo André, SP, Brazil.
Flavio da Silva EmeryFaculty of Pharmaceutical Sciences, University of São Paulo, Ribeirão Preto, SP, Brazil.
Kathia Maria HonorioCenter for Natural and Human Sciences, Federal University of ABC, Santo André, SP, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The discovery of new drugs for neglected tropical diseases (NTDs) is challenging due to the complexity of parasite-host interactions, causing resistance and the scarcity of financial resources. However, computational techniques, particularly molecular docking, have made significant advancements. This approach allows for the virtual screening of large compound libraries against specific molecular targets in parasites, efficiently cost-effectively identifying potential drug candidates. On the other hand, reverse docking seeks biological targets that can interact with specific substances of interest, integrating structural data from parasitic proteins with chemical information. Integrating computational approaches with experimental data drives the discovery of new therapeutic targets and the optimization of candidate compounds. In addition, artificial intelligence and molecular docking offer an innovative approach, enhancing prediction accuracy and driving advancements in discovering new treatments for NTDs. Thus, the primary focus of this review is to present the relevance, evolution, and prospects of the use of molecular docking techniques in the discovery and design of drug candidates for neglected diseases, despite advancements, challenges persist, including the need for increased investment in research and development, validation of predictive results, and collaboration among institutions. In this study, we aim to address the significant advancements in molecular docking and how this technique, along with modern medicinal chemistry tools, has been relevant in discovering and designing drug candidates for neglected diseases.

Indexed as

Molecular Docking SimulationNeglected DiseasesAnimalsDrug DiscoveryHumansTropical Medicinein silico techniquesmodern medicinal chemistrymolecular dockingNeglected tropical diseasesparasite-host interactions.potential drug candidates

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.